HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multimodal cancer chemotherapy during the first and second trimester of pregnancy: a case report.

Abstract
This paper reports treatment with combined chemotherapy during pregnancy. A 39-year-old woman with breast cancer was given adjuvant chemotherapy including cyclophosphamide, methotrexate and 6-fluorouracil from the 6th to the 24th week of gestation. The possibility of teratogenic effects on the fetus was explained to the patient however she refused to terminate the pregnancy. A 30-week male infant with only a minor malformation was delivered. The authors reviewed the literature regarding chemotherapeutic agents given during the first trimester of pregnancy. Most cytotoxic drugs have teratogenic effects on experimental animal subjects. However, actual data on human fetuses are sparse because of the variety of therapeutic regimens and the rarity of administering chemotherapy during pregnancy. The long-term effects of exposure to cytotoxic drugs in utero, needs further research.
AuthorsC Giannakopoulou, A Manoura, E Hatzidaki, E Korakaki, G Froudarakis, E Koumandakis
JournalEuropean journal of obstetrics, gynecology, and reproductive biology (Eur J Obstet Gynecol Reprod Biol) Vol. 91 Issue 1 Pg. 95-7 (Jul 2000) ISSN: 0301-2115 [Print] Ireland
PMID10817888 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Breast Neoplasms (drug therapy, pathology, surgery)
  • Carcinoma, Ductal, Breast (drug therapy, secondary, surgery)
  • Chemotherapy, Adjuvant
  • Female
  • Hernia, Inguinal (etiology, surgery)
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Liver Neoplasms (drug therapy, secondary)
  • Male
  • Mastectomy, Modified Radical
  • Pregnancy
  • Pregnancy Complications, Neoplastic (drug therapy)
  • Pregnancy Trimester, First
  • Pregnancy Trimester, Second
  • Prenatal Exposure Delayed Effects

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: